Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studies (original) (raw)

References

• Ansari B, Coates PJ, Greenstein BD, Hall PA (1993) In situ endlabelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 170:1–8
  PubMed Google Scholar
• Arends MJ, McGregor AH, Toft NJ, Brown EJH, Wyllie AH (1993) Susceptibility to apoptosis is differentially regulated by c-myc and Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer 68:1127–1133
  PubMed Google Scholar
• Arends MJ, McGregor AH, Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed_myc, ras_, and_HPV_ oncogenes. Am J Pathol 144:1045–1057
  PubMed Google Scholar
• Barbacid M (1987)ras genes. Annu Rev Biochem 56:779–927
  PubMed Google Scholar
• Bernards A (1995) Neurofibromatosis type 1 and Ras-mediated signalling: filling in the gaps. Biochim biophys Acta 1242:43–59
  PubMed Google Scholar
• Bissonnette RP, Echeverri F, Mahboubi A, Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by_bcl-2_. Nature 359:552–554
  PubMed Google Scholar
• Bos JL (1988) The_ras_ gene family and human carcinogenesis. Mutat Res 195:255–271
  PubMed Google Scholar
• Bos JL (1989)ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689
  PubMed Google Scholar
• Bos JL (1995) P21Ras: an oncoprotein functioning in growth factor-induced signal transduction. Eur J Cancer 31A:1051–1054
  Google Scholar
• Burt RK, Garfield S, John K, Thorgeirsson SS (1988) Transformation of rat liver epithelial cells with v-Ha-ras or v-raf causes expression of MDR-1, glutathione-_S_-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 9:2329–2332
  PubMed Google Scholar
• Calabretta B, Skorski T, Szczylik C, Zon G (1993) Prospects for gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treat Rev 19:169–179
  PubMed Google Scholar
• Carson DN, Riboro JM (1993) Apoptosis and disease. Lancet 341:1251–1254
  PubMed Google Scholar
• Carter G, Lemoine NR (1993) Antisense technology for cancer therapy: does it make sense? Br J Cancer 67:869–876
  PubMed Google Scholar
• Charlotte F, Lermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES (1994) Immunohistochemical detection of_bcl-2_ protein in normal and pathological human liver. Am J Pathol 144:460–465
  PubMed Google Scholar
• Chen CH, Zhang J, Ling CC (1994) Transfected c-myc and c-Ha-ras modulate radiation-induced apoptosis in rat embryo cells. Radiat Res 139:307–315
  PubMed Google Scholar
• Chen FH, Xia QJ, Li YX (1991) RNA-RNA in situ hybridization for study of expression of c-myc and H-_ras_-1 genes in human primary liver cell carcinoma. Tumor (Shanghai) 11:193–194
  Google Scholar
• Cheng RM, Chu TH, Yeh HJ, et al. (1979) Establishment of three human hepatocellular carcinoma cell lines cultured in vitro and their characteristics. China Sci 12:1225–1233
  Google Scholar
• Chin KV, Ueda K, Pastan I, Gottesman MM (1992) Modulation of activity of the promotor of the human_MDR1_ gene by_ras_ and p53. Science 255:459–462
  PubMed Google Scholar
• Clarke AR, Purdie CA, Harrison DJ, Bird CC, Hooper ML, Wyllie AH (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849–852
  PubMed Google Scholar
• Cohen JJ (1993) Apoptosis. Immunol Today 14:126–130
  PubMed Google Scholar
• Collins MKL, Revas AL (1993) The control of apoptosis in mammalian cells. Trends Biol Sci 18:307–309
  Google Scholar
• Compton MM (1992) A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev 11:105–119
  PubMed Google Scholar
• Crook AT (1993) Progress toward oligonuleotide therapeutics pharmacodynamic properties. FASEB J 7:533–539
  PubMed Google Scholar
• Eastman A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin Cancer Biol 6:45–53
  PubMed Google Scholar
• Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119–128
  PubMed Google Scholar
• Fanidi A, Harrington EA, Aevan GI (1992) Cooperative interaction between c-myc and_bcl-2_ proto-oncogenes. Nature 359:554–556
  PubMed Google Scholar
• Fernandez A, Fosdick LJ, Marin MC, Diaz C, McDonnell TJ, Ananthaswamy HN, McConkey DJ (1995) Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2. Oncogene 10: 769–774
  PubMed Google Scholar
• Fernandez-Sarabia MJ, Bishoff JR (1994)bcl-2 associated with the_ras_-related protein R-ras p23. Nature 366:274–275
  Google Scholar
• Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol 124:619–626
  PubMed Google Scholar
• Gray GD, Hernandez OM, Hebel D, Root M, Pow-Sang JM, Wickstrom E (1993) Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice. Cancer Res 53:577–580
  PubMed Google Scholar
• Greig RG, Koestler TP, Trainer DL, Corwin SP, Miles L, Kline T, Sweet R, Yokoyama S, Poste G (1985) Tumorigenic and metastatic properties of normal and_ras_-transfected NIH 3T3 cells. Proc Natl Acad Sci USA 82:3698–3701
  PubMed Google Scholar
• Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F (1995) Fas-induced apoptosis is mediated via a ceramide-initiates Ras signaling pathway. Immunity 2:341–351
  PubMed Google Scholar
• Harrington EA, Fanidi A, Evan GI (1994) Oncogenes and cell death. Curr Opin Genet Dev 4:120–129
  PubMed Google Scholar
• Helene C (1991) Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotides. Eur J Cancer 27:1460–1471
  Google Scholar
• Hockenbery DM, Oltvai ZN, Yin XM, Milliamanb CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251
  PubMed Google Scholar
• Hofmann M, Rudy W, Gunthert U, Zimmer SG, Zawadzki V, Zoller M, Lichtner RB, Herrlich P, Ponta H (1993) A link between_ras_ and metastatic behavior of tumor cells:ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53:1516–1521
  PubMed Google Scholar
• Hu QJ, Klippel A, Muslin AJ, Fantl WJ, Williams LT (1995) Rasdependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268:100–102
  PubMed Google Scholar
• Huschtscha LI, Jeitner TM, Andersson CE, Bartier WA, Tattersall MHN (1994) Identification of apoptotic and necrotic human leukemic cells by flow cytometry. Exp Cell Res 212:161–165
  PubMed Google Scholar
• Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 259:295–300
  Google Scholar
• Kerbel RS, Kobayashi H, Graham CH (1994) Intrinsic or acquired drug resistance and metastasis: are they linked phenotypes? J Cell Biochem 56:37–47
  PubMed Google Scholar
• Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–245
  PubMed Google Scholar
• Khosravi-Far R, Der CJ (1994) The Ras signal transduction pathway. Cancer Metastasis Rev 13:67–89
  PubMed Google Scholar
• Laio Y, Tang ZY, Liu KD (1994) Protooncogenes and apoptosis. Chin J Cancer Biother 1:70–74
  Google Scholar
• Lee EY, Chang CY, Hu N, Wang YCJ, Lai CC, Herrup K, Lee WH (1992) Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 259:288–294
  Google Scholar
• Lin HJ, Eviner V, Prendergast GC, White E (1995) Activated H-ras rescues E1A-induced apoptosis and cooperate with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 15:4536–4544
  PubMed Google Scholar
• Lowe SW, Ruley HE, Jacks T, Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74:957–967
  PubMed Google Scholar
• Malcomson RD, Oren M, Wyllie AH, Harrison DJ (1995) P53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 72:952–957
  PubMed Google Scholar
• Marshall MS (1995) Ras target proteins in eukaryotic cells. FASEB J 9:1311–1318
  PubMed Google Scholar
• Martin SJ, Green DR (1995) Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit Rev Oncol Hematol 18:137–153
  PubMed Google Scholar
• McConkey DJ, Fernandez A, Trent J, Ananthaswamy HN (1995) Oncogene regulation of endonuclease activation in apoptosis. Cancer Lett 94:9–16
  PubMed Google Scholar
• Metelev V, Agrawal S (1992) Ion-exchange high-performance liquid chromatography analysis of oligodeoxyribonucleotide phosphorothioates. Anal Biochem 200:342–346
  PubMed Google Scholar
• Milligan JF, Matteucci MD, Martin JC (1993) Current concepts in antisense drug design. J Med Chem 36:1923–1937
  PubMed Google Scholar
• Mirabelli CK, Crooke ST (1993) Antisense oligonucleotides in the context of modern molecular drug discovery and development. In: Antisense research and applications. Crooke ST, Bernard L (eds) CRC, Boca Raton, Fla, pp 7–35
  Google Scholar
• Mitsuhashi BY, Filmus BJ, Shirasawa S, Sasazuki T, Kerbel RS (1995) Mutant_ras_ oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumour angiogenesis. Cancer Res 55:4575–4580
  PubMed Google Scholar
• Moore J, Boswell S, Hoffman R, Burgess G, Hromas R (1993) Mutation H-ras over-expression inhibits a random apoptotic nuclease in myeloid leukemia cells. Leuk Res 17:703–709
  PubMed Google Scholar
• Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271–279
  PubMed Google Scholar
• Nooter K, Boersma AWM, Oostrum RG, Burger H, Jochemsen A, Stoter G (1995) Constitutive expression of the c-H-ras oncogene inhibit doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line. Br J Cancer 71:556–561
  PubMed Google Scholar
• Oberhammer FA, Pavelka M, Shama S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89:5408–5412
  PubMed Google Scholar
• Oren M (1992) The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11:141–148
  PubMed Google Scholar
• Packham G, Cleveland JL (1995) C-myc and apoptosis. Biochim Biophys Acta 1242:11–28
  PubMed Google Scholar
• Patel T, Gores GJ (1995) Apoptosis and hepatobiliary disease. Hepatology 21:1725–1741
  PubMed Google Scholar
• Reddy EP (1983) Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 220:1061–1063
  PubMed Google Scholar
• Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1–6
  PubMed Google Scholar
• Rose JK, Gallione CJ (1981) Nucleotide sequences of the mRNAs encoding the vesicular stomatosis G and M proteins determined from cDNA clones containing the complete coding regions. J Virol 39:519–528
  PubMed Google Scholar
• Sakai N, Ogiso Y, Fujita H, Watari H, Koike T, Kuzumaki N (1994) Induction of apoptosis by a dominant negative H-ras mutant (116Y) in K562 cells. Exp Cell Res 215:131–136
  PubMed Google Scholar
• Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G, Kashani-Sabet MK (1995) Oligonucleotidemediated modulation of mammalian gene expression. FASEB J 9:1288–1296
  PubMed Google Scholar
• Schwartz LM, Osborne BA (1993) Programmed cell death, apoptosis and killer genes. Immunol Today 14:582–590
  PubMed Google Scholar
• Shack S, Chen LC, Miller AC, Danes R, Amid D (1995) Increased susceptibility of_ras_-transformed cells to phenylacetate is associated with inhibition of p21 ras isoprenylation and phenotypic reversion. Int J Cancer 63:124–129
  PubMed Google Scholar
• Shaw P, Bovey R, Tardy S, Sahli R, Sordt B, Costa J (1992) Induction of apoptosis by wild-type p53 in a colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495–4499
  PubMed Google Scholar
• Spaargaren M, Martin GA, McCorcomick F, Fernandez-Sarabia MJ, Bischoff JR (1994) The_ras_-related protein R-ras interacts directly with Raf-1 in a GTP-dependent manner. Biochem J 300:303–307
  PubMed Google Scholar
• Spaargaren M, Bischoff JR, McCormick F (1995) Signal transduction by Ras-like GTPases: a potential target for anticancer drugs. Gene Expr 4:345–356
  PubMed Google Scholar
• Stein CA, Cheng YC (1993) Antisense olignucleotides as therapeutic agents-is the bullet really magical? Science 261:1004–1012
  PubMed Google Scholar
• Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1445–1449
  PubMed Google Scholar
• Stewart BW (1994) Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 17:1286–1296
  Google Scholar
• Tabor E (1994) Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42:357–365
  PubMed Google Scholar
• Tang ZY (1996) Small hepatocellular carcinoma: past, present and future. Chin Med J 109:21–24
  PubMed Google Scholar
• Thompson CB (1995) Apoptosis in pathogenesis and treatment of disease. Science 267:1456–1462
  PubMed Google Scholar
• Wagner RW (1994) Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333–335
  PubMed Google Scholar
• Wickstrom EL, Bacon TA, Gonzalez A, Freeman DL, Lyman GH, Wicksrom E (1988) Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci USA 85:1028–1032
  PubMed Google Scholar
• Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74:777–779
  PubMed Google Scholar
• Wong Y, Lin ZY (1996) Preliminary study on the relationship between the H-ras oncogene and the metastasis or invasion of hepatocellular carcinoma. In: Tang ZY, Ye SL (eds) Recent progress in liver cancer and hepatitis. Beijing International Academic Publishers, Beijing, p 80
  Google Scholar
• Wood AC, Waters CM, Garner A, Hickman JA (1994) Changes in c-myc expression and kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells. Br J Cancer 69:663–669
  PubMed Google Scholar
• Wyllie AH (1992) Apoptosis and regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11:95–103
  PubMed Google Scholar
• Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA (1987) Rodent fibroblast tumors expressing human_myc_ and_ras_ genes: growth, metastasis and endogenous oncogene expression. Br J Cancer 56:251–259
  PubMed Google Scholar
• Zon G, Geiser TG (1991) Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future direction. Anticancer Drug Des 6:539–568
  PubMed Google Scholar

Download references